BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33310857)

  • 1. Quality of CD8
    O'Melia MJ; Rohner NA; Manspeaker MP; Francis DM; Kissick HT; Thomas SN
    Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33310857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC.
    O'Melia MJ; Manspeaker MP; Thomas SN
    Cancer Immunol Immunother; 2021 Aug; 70(8):2179-2195. PubMed ID: 33459842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
    Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
    J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes.
    Leary N; Walser S; He Y; Cousin N; Pereira P; Gallo A; Collado-Diaz V; Halin C; Garcia-Silva S; Peinado H; Dieterich LC
    J Extracell Vesicles; 2022 Feb; 11(2):e12197. PubMed ID: 35188342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivered antigen peptides to resident CD8α
    Wang L; Wang Z; Qin Y; Liang W
    Eur J Pharm Biopharm; 2020 Feb; 147():76-86. PubMed ID: 31887349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.
    Kimura T; Sugaya M; Oka T; Blauvelt A; Okochi H; Sato S
    Oncotarget; 2015 Jul; 6(20):18081-93. PubMed ID: 26098776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.
    Mackensen A; Meidenbauer N; Vogl S; Laumer M; Berger J; Andreesen R
    J Clin Oncol; 2006 Nov; 24(31):5060-9. PubMed ID: 17075125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response.
    Nakamura Y; Fujisawa Y; Okiyama N; Watanabe R; Tanaka R; Ishitsuka Y; Tahara H; Fujimoto M
    J Dermatol Sci; 2018 Apr; 90(1):46-51. PubMed ID: 29352630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic CD8
    Rahim MK; Okholm TLH; Jones KB; McCarthy EE; Liu CC; Yee JL; Tamaki SJ; Marquez DM; Tenvooren I; Wai K; Cheung A; Davidson BR; Johri V; Samad B; O'Gorman WE; Krummel MF; van Zante A; Combes AJ; Angelo M; Fong L; Algazi AP; Ha P; Spitzer MH
    Cell; 2023 Mar; 186(6):1127-1143.e18. PubMed ID: 36931243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumor expanded T cell clones can be non-sentinel lymph node derived in breast cancer revealed by single-cell immune profiling.
    Jiao S; Xiong Q; Yan M; Zhan X; Yang Z; Peng C; Sun B; Pang D; Liu T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34992092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic PD-L1 Expression Restricts Tumor-Specific CD8
    Cousin N; Cap S; Dihr M; Tacconi C; Detmar M; Dieterich LC
    Cancer Res; 2021 Aug; 81(15):4133-4144. PubMed ID: 34099493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes.
    Braza MS; Caraux A; Rousset T; Lafaye de Micheaux S; Sicard H; Squiban P; Costes V; Klein B; Rossi JF
    J Immunol; 2010 Jan; 184(1):134-40. PubMed ID: 19949101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
    Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
    Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients.
    Vuletić A; Jovanić I; Jurišić V; Milovanović Z; Nikolić S; Spurnić I; Konjević G
    Pathol Oncol Res; 2020 Jan; 26(1):223-231. PubMed ID: 29948616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.
    Vuylsteke RJ; van Leeuwen PA; Meijer S; Wijnands PG; Statius Muller MG; Busch DH; Scheper RJ; de Gruijl TD
    Am J Pathol; 2002 Jul; 161(1):19-26. PubMed ID: 12107085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
    Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
    Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
    Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
    J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.
    Walker EB; Miller W; Haley D; Floyd K; Curti B; Urba WJ
    Clin Cancer Res; 2009 Apr; 15(7):2541-51. PubMed ID: 19318471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.